Followers | 15 |
Posts | 2103 |
Boards Moderated | 0 |
Alias Born | 07/01/2016 |
Wednesday, February 15, 2023 5:56:02 AM
MONTHLY PROGRESS REPORT - February 6, 2023
Intellabridge Technology Corporation (CSE: KASH) (OTCQB: KASHF) (FSE: KASH)
is a fintech company in the business of impact finance. Intellabridge’s product, Kash is
a savings, payments and investment application providing customers with cashback
which can be donated to charities based on the United Nations Sustainable
Development Goals. The Kash 2.0 product, which is expected to launch in March 2023,
offers customers self-custody services, automated donation systems, and hardware
security features, with plans to offer cashback debit cards, virtual cards, Apple Pay and
Google Pay.
The Kash platform is available on web and mobile at kash.io
For more information on Intellabridge, visit www.intellabridge.com
The Company continues to develop its Kash 2.0 product which includes six modules:
1. Debit Cards (Mastercard)
2. Merchant Cashback
3. Impact donation system (SDG)
4. Decentralized investment app (DEX)
5. Hardware security solution (YubiKey)
6. Referral system (SoFi)
The Alpha version of the product is currently in the testing phase. Private beta is
expected to start in February 2023 ahead of the planned product launch in March 2023.
The Company has been in communication with the Ontario Securities Commission (the
"OSC") with respect to the revocation of the cease trade order affecting the securities of
the Company that was issued by the OSC on May 6, 2022 (the "CTO"), and which, when
revoked, will allow the common shares of the Company to resume trading on the
Canadian Securities Exchange. The Company has answered questions on the
Company's business posed by the OSC and provided draft documents requested by the
OSC and will continue to work closely with the OSC towards revocation of the CTO in
an expeditious manner.
https://webfiles.thecse.com/5_-_FORM_7_-_January_2023_-_Final.pdf?mJy8Y8SP.rZLMyW_hSAoWH_TC9gsitYI
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM